Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 2 April 2024
Name of applicant: |
Hikma Pharmaceuticals PLC |
||
Name of scheme: |
Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans") |
||
Period of return |
From: 1 October 2023 |
To: |
31 March 2024 |
Balance of unallotted securities under scheme(s) from previous return: |
The Plans: 1,118,710 Ordinary Shares of 10 pence |
||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
The Plans: 0 Ordinary Shares of 10 pence |
||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
2018 MIP: 494,322 Ordinary Shares of 10 pence EIP: 311,764 Ordinary Shares of 10 pence |
||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
The Plans: 312,624 Ordinary Shares of 10 pence |
Name of contact: |
Helen Middlemist |
Telephone number of contact: |
+44(0)20 7399 2760 |
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI: 549300BNS685UXH4JI75)